Cargando…

Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study

BACKGROUND: 6-mercaptopurine (6-MP) is an essential component of pediatric acute lymphoblastic leukemia (ALL) maintenance therapy. Individual variability in this drug-related toxicity could be attributed in part to genetic polymorphism thiopurine methyltransferase (TPMT). AIM: To investigate the fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Rashedy, Farida H., Ragab, Seham Mohammed, Dawood, Ashraf A., Temraz, Shaymaa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711227/ https://www.ncbi.nlm.nih.gov/pubmed/26811598 http://dx.doi.org/10.4103/0971-5851.171553

Ejemplares similares

Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
por: Linga, Vijay Gandhi, et al.
Publicado: (2014)

Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan
por: Alsous, Mervat, et al.
Publicado: (2018)

Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia
por: KÜPELİ, Serhan
Publicado: (2015)

Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia
por: Azimi, F, et al.
Publicado: (2014)

Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients
por: Ayesh, Basim Mohammad, et al.
Publicado: (2013)

Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
por: Abaji, Rachid, et al.
Publicado: (2017)

Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
por: Lennard, Lynne, et al.
Publicado: (2014)

Thiopurine S-Methyltransferase Polymorphisms in Korean Dermatologic Patients
por: Lee, Minseok, et al.
Publicado: (2017)

Assessment of Obesity and Hepatic Late Adverse Effects in the Egyptian Survivors of Pediatric Acute Lymphoblastic Leukemia: a Single Center Study
por: El-Rashedy, Farida H., et al.
Publicado: (2017)

Polymorphisms of the thiopurine methyl transferase gene in healthy and acute lymphoblastic leukemia mestizos
por: Candelaria, Myrna, et al.
Publicado: (2007)

Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
por: Zeglam, Hamza Ben, et al.
Publicado: (2015)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003
por: Lennard, Lynne, et al.
Publicado: (2015)

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2023)

Thiopurine S-Methyltransferase Polymorphisms Predict Hepatotoxicity in Azathioprine-Treated Patients with Autoimmune Diseases
por: Sheu, Heh-Shiang, et al.
Publicado: (2022)

Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism
por: Zimdahl Kahlin, Anna, et al.
Publicado: (2020)

Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia
por: Moon, Soo Young, et al.
Publicado: (2019)

Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
por: Liu, Yue-Ping, et al.
Publicado: (2015)

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk
por: Nguyen, Christine M., et al.
Publicado: (2011)

Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
por: Zalizko, Polina, et al.
Publicado: (2020)

A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia
por: ElHarouni, Dina, et al.
Publicado: (2018)

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia
por: Evensen, Nikki A., et al.
Publicado: (2018)

Severe Myelotoxicity Associated with Thiopurine S-Methyltransferase*3A/*3C Polymorphisms in a Patient with Pediatric Leukemia and the Effect of Steroid Therapy
por: Belen, Burcu Fatma, et al.
Publicado: (2014)

Multilocus Genotypes of Relevance for Drug Metabolizing Enzymes and Therapy with Thiopurines in Patients with Acute Lymphoblastic Leukemia
por: Stocco, Gabriele, et al.
Publicado: (2013)

Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia
por: Larsen, Rikke Hebo, et al.
Publicado: (2021)

Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia
por: Correa-Jimenez, Oscar, et al.
Publicado: (2021)

Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values
por: Adehin, Ayorinde, et al.
Publicado: (2018)

Thiopurine S-methyltransferase and Pemphigus Vulgaris: A Phenotype-Genotype Study
por: Mokhtari, Maral, et al.
Publicado: (2020)

Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease
por: Su, Song-Sen, et al.
Publicado: (2020)

Evaluation of Glutathione-S-Transferase P1 Polymorphism and its Relation to Bone Mineral Density in Egyptian Children and Adolescents with Beta-Thalassemia Major
por: Ragab, Seham M., et al.
Publicado: (2016)

Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose
por: Yin, Dandan, et al.
Publicado: (2017)

Vitamin D receptor gene polymorphism in Egyptian pediatric acute lymphoblastic leukemia correlation with BMD
por: Tantawy, Maha, et al.
Publicado: (2016)

Clinical significance of thymidine kinase in Egyptian children with acute lymphoblastic leukemia
por: Hagag, Adel A., et al.
Publicado: (2015)

Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods
por: Asadov, Chingiz, et al.
Publicado: (2017)

Scorpion primer PCR analysis for genotyping of allele variants of thiopurine s-methyltransferase*3
por: Yao, Pu, et al.
Publicado: (2020)

Importance of NUDT15 Polymorphisms in Thiopurine Treatments
por: Tanaka, Yoichi, et al.
Publicado: (2021)

PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy
por: Smid, Alenka, et al.
Publicado: (2016)

Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis
por: Liu, Yue-Ping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qn9g5r1m6dv13f6f3tfq79dcpl